Clearstead Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $52.4K | Sell |
834
-3,663
| -81% | -$255K | ﹤0.01% | 1271 |
|
|
2025
Q4 | $298K | Buy |
4,497
+2,653
| +144% | +$172K | ﹤0.01% | 822 |
|
|
2025
Q3 | $124K | Sell |
1,844
-817
| -31% | -$64.7K | ﹤0.01% | 996 |
|
|
2025
Q2 | $232K | Buy |
2,661
+1,883
| +242% | +$148K | ﹤0.01% | 849 |
|
|
2025
Q1 | $53.1K | Sell |
778
-428
| -35% | -$34.9K | ﹤0.01% | 1159 |
|
|
2024
Q4 | $93.8K | Sell |
1,206
-129
| -10% | -$9.55K | ﹤0.01% | 1041 |
|
|
2024
Q3 | $89.5K | Sell |
1,335
-675
| -34% | -$55.4K | ﹤0.01% | 1058 |
|
|
2024
Q2 | $228K | Buy |
2,010
+184
| +10% | +$23.3K | ﹤0.01% | 783 |
|
|
2024
Q1 | $228K | Buy |
1,826
+19
| +1% | +$2.39K | 0.01% | 447 |
|
|
2023
Q4 | $224K | Sell |
1,807
-1,707
| -49% | -$174K | 0.01% | 442 |
|
|
2023
Q3 | $328K | Buy |
3,514
+1,697
| +93% | +$191K | 0.01% | 469 |
|
|
2023
Q2 | $234K | Buy |
1,817
+1,235
| +212% | +$149K | 0.01% | 410 |
|
|
2023
Q1 | $67.6K | Buy |
582
+48
| +9% | +$5.37K | ﹤0.01% | 592 |
|
|
2022
Q4 | $60.5K | Buy |
534
+52
| +11% | +$5.71K | ﹤0.01% | 598 |
|
|
2022
Q3 | $39K | Hold |
482
| – | – | ﹤0.01% | 657 |
|
|
2022
Q2 | $36K | Buy |
482
+50
| +12% | +$4.56K | ﹤0.01% | 688 |
|
|
2022
Q1 | $55K | Hold |
432
| – | – | ﹤0.01% | 658 |
|
|
2021
Q4 | $58K | Sell |
432
-228
| -35% | -$32.8K | ﹤0.01% | 632 |
|
|
2021
Q3 | $90K | Buy |
660
+228
| +53% | +$28.8K | 0.01% | 505 |
|
|
2021
Q2 | $46K | Hold |
432
| – | – | ﹤0.01% | 570 |
|
|
2021
Q1 | $39K | Hold |
432
| – | – | ﹤0.01% | 580 |
|
|
2020
Q4 | $40K | Sell |
432
-48
| -10% | -$4.29K | ﹤0.01% | 538 |
|
|
2020
Q3 | $49K | Buy |
480
+80
| +20% | +$8.36K | 0.01% | 468 |
|
|
2020
Q2 | $41K | Hold |
400
| – | – | ﹤0.01% | 452 |
|
|
2020
Q1 | $27K | Buy |
+400
| New | +$24.9K | ﹤0.01% | 473 |
|
Other funds holding DXCM
VCM
VPM
